BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30850667)

  • 1. Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer.
    Lin PC; Yeh YM; Wu PY; Hsu KF; Chang JY; Shen MR
    Sci Rep; 2019 Mar; 9(1):3931. PubMed ID: 30850667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.
    You YN; Borras E; Chang K; Price BA; Mork M; Chang GJ; Rodriguez-Bigas MA; Bednarski BK; Meric-Bernstam F; Vilar E
    Dis Colon Rectum; 2019 Apr; 62(4):429-437. PubMed ID: 30730459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
    Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L
    Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.
    Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT
    PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
    Chang PY; Chen JS; Chang NC; Chang SC; Wang MC; Tsai SH; Wen YH; Tsai WS; Chan EC; Lu JJ
    Oncotarget; 2016 Jun; 7(25):37566-37580. PubMed ID: 27121310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Relevance of Frequent Germline Genetic Variants Detected by Targeted Sequencing in Patients With Rectal Adenocarcinoma (READ).
    Huang KC; Chiang SF; Ke TW; Chen WT; Chen TW; Chao KC
    Cancer Genomics Proteomics; 2020; 17(3):291-299. PubMed ID: 32345670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the
    Morak M; Ibisler A; Keller G; Jessen E; Laner A; Gonzales-Fassrainer D; Locher M; Massdorf T; Nissen AM; Benet-Pagès A; Holinski-Feder E
    J Med Genet; 2018 Apr; 55(4):240-248. PubMed ID: 29472279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy.
    Lin PC; Yeh YM; Chan RH; Lin BW; Chen PC; Pan CC; Shen MR
    BMC Cancer; 2021 Mar; 21(1):217. PubMed ID: 33653301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations.
    Kraus C; Rau TT; Lux P; Erlenbach-Wünsch K; Löhr S; Krumbiegel M; Thiel CT; Stöhr R; Agaimy A; Croner RS; Stürzl M; Hohenberger W; Hartmann A; Reis A
    Int J Cancer; 2015 Mar; 136(6):E559-68. PubMed ID: 25142776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.
    Ten Broeke SW; van Bavel TC; Jansen AML; Gómez-García E; Hes FJ; van Hest LP; Letteboer TGW; Olderode-Berends MJW; Ruano D; Spruijt L; Suerink M; Tops CM; van Eijk R; Morreau H; van Wezel T; Nielsen M
    Gastroenterology; 2018 Sep; 155(3):844-851. PubMed ID: 29758216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
    Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
    Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characteristics of young-onset colorectal cancer in Vietnamese patients.
    Do MD; Nguyen TH; Le KT; Le LHG; Nguyen BH; Le KT; Doan TPT; Ho CQ; Nguyen HN; Tran TD; Vu HA
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):678-685. PubMed ID: 35098669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.
    Bellido F; Sowada N; Mur P; Lázaro C; Pons T; Valdés-Mas R; Pineda M; Aiza G; Iglesias S; Soto JL; Urioste M; Caldés T; Balbín M; Blay P; Rueda D; Durán M; Valencia A; Moreno V; Brunet J; Blanco I; Navarro M; Calin GA; Borck G; Puente XS; Capellá G; Valle L
    Gastroenterology; 2018 Jan; 154(1):181-194.e20. PubMed ID: 28912018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between germline variants and somatic mutations in colorectal cancer.
    Barfield R; Qu C; Steinfelder RS; Zeng C; Harrison TA; Brezina S; Buchanan DD; Campbell PT; Casey G; Gallinger S; Giannakis M; Gruber SB; Gsur A; Hsu L; Huyghe JR; Moreno V; Newcomb PA; Ogino S; Phipps AI; Slattery ML; Thibodeau SN; Trinh QM; Toland AE; Hudson TJ; Sun W; Zaidi SH; Peters U
    Sci Rep; 2022 Jun; 12(1):10207. PubMed ID: 35715570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients.
    Lin PC; Chen HO; Lee CJ; Yeh YM; Shen MR; Chiang JH
    Hum Genomics; 2021 Jan; 15(1):3. PubMed ID: 33431054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited DNA-Repair Defects in Colorectal Cancer.
    AlDubayan SH; Giannakis M; Moore ND; Han GC; Reardon B; Hamada T; Mu XJ; Nishihara R; Qian Z; Liu L; Yurgelun MB; Syngal S; Garraway LA; Ogino S; Fuchs CS; Van Allen EM
    Am J Hum Genet; 2018 Mar; 102(3):401-414. PubMed ID: 29478780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations and germline sequence variants in patients with familial colorectal cancer.
    Gylfe AE; Sirkiä J; Ahlsten M; Järvinen H; Mecklin JP; Karhu A; Aaltonen LA
    Int J Cancer; 2010 Dec; 127(12):2974-80. PubMed ID: 21351276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape of somatic mutated genes and inherited susceptibility genes in gynecological cancer.
    Watanabe T; Soeda S; Okoshi C; Fukuda T; Yasuda S; Fujimori K
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2629-2643. PubMed ID: 37632362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.